PPD Extract Induces the Maturation of Human Monocyte-Derived Dendritic Cells

RERERENCES

• Adams S., O'Neill D.W., Bhardwaj N. Recent advances in dendritic cell biology. J. Clin. Immunol. 2005; 25(3)177–188
   PubMed Web of Science ®Google Scholar
• Granucci F., Foti M., Ricciardi-Castagnoli P. Dendritic cell biology. Adv. Immunol. 2005; 88: 193–233
   PubMed Web of Science ®Google Scholar
• Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000; 18: 767–811
   PubMed Web of Science ®Google Scholar
• Gatti E., Pierre P. Understanding the cell biology of antigen presentation: the dendritic cell contribution. Curr. Opin. Cell Biol. 2003; 15(4)468–473
   PubMed Web of Science ®Google Scholar
• Brunner C., Seiderer J., Schlamp A., Bidlingmaier M., Eigler A., Haimerl W., Lehr H.A., Krieg A.M., Hartmann G., Endres S. Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo. J. Immunol. 2000; 165(11)6278–6286
   PubMed Web of Science ®Google Scholar
• Wurtzen P.A., Nissen M.H., Claesson M.H. Maturation of dendritic cells by recombinant human CD40L-trimer leads to a homogeneous cell population with enhanced surface marker expression and increased cytokine production. Scand. J. Immunol. 2001; 53(6)579–587
   PubMed Web of Science ®Google Scholar
• Hart D.N. Dendritic cell biology evolves into clinical application. Lancet. 2005; 365(9454)102–104
   PubMed Web of Science ®Google Scholar
• Proudfoot O., Pouniotis D., Sheng K.C., Loveland B.E., Pietersz G.A. Dendritic cell vaccination. Expert Rev. Vaccines. 2007; 6(4)617–633
   PubMed Web of Science ®Google Scholar
• Chapuis F., Rosenzwajg M., Yagello M., Ekman M., Biberfeld P., Gluckman J.C. Differentiation of human dendritic cells from monocytes in vitro. Eur. J. Immunol. 1997; 27(2)431–441
   PubMed Web of Science ®Google Scholar
• Decker W.K., Xing D., Shpall E.J. Dendritic cell immunotherapy for the treatment of neoplastic disease. Biol. Blood Marrow Transplant. 2006; 12(2)113–125
   PubMed Web of Science ®Google Scholar
• Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994; 179(4)1109–1118
   PubMed Web of Science ®Google Scholar
• Canque B., Camus S., Yagello M., Gluckman J.C. IL-4 and CD40 ligation affect differently the differentiation, maturation, and function of human CD34+ cell-derived CD1a+CD14- and CD1a-CD14+ dendritic cell precursors in vitro. J. Leukoc. Biol. 1998; 64(2)235–244
   PubMed Web of Science ®Google Scholar
• Granucci F., Ferrero E., Foti M., Aggujaro D., Vettoretto K., Ricciardi-Castagnoli P. Early events in dendritic cell maturation induced by LPS. Microbes Infect. 1999; 1(13)1079–1084
   PubMed Web of Science ®Google Scholar
• Kobayashi T., Walsh P.T., Walsh M.C., Speirs K.M., Chiffoleau E., King C.G., Hancock W.W., Caamano J.H., Hunter C.A., Scott P., Turka L.A., Choi Y. TRAF6 is a critical factor for dendritic cell maturation and development. Immunity 2003; 19(3)353–363
   PubMed Web of Science ®Google Scholar
• Morel Y., Truneh A., Sweet R.W., Olive D., Costello R.T. The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity. J. Immunol. 2001; 167(5)2479–2486
   PubMed Web of Science ®Google Scholar
• Tuyaerts S., Aerts J.L., Corthals J., Neyns B., Heirman C., Breckpot K., Thielemans K., Bonehill A. Current approaches in dendritic cell generation and future implications for cancer immunotherapy. Cancer Immunol. Immunother. 2007; 56(10)1513–1537
   PubMed Web of Science ®Google Scholar
• Sharbaugh R.J. Administering and interpreting the PPD tuberculin skin test. Home Care Provid. 1998; 3(3)141–143
   PubMedGoogle Scholar
• Landi S., Held H.R. Preparation and characterization of a large batch of tuberculin purified protein derivate (PPD-CT68). Ann. Sclavo. 1980; 22(6)899–907
   PubMedGoogle Scholar
• Pais T.F., Silva R.A., Smedegaard B., Appelberg R., Andersen P. Analysis of T cells recruited during delayed-type hypersensitivity to purified protein derivative (PPD) versus challenge with tuberculosis infection. Immunology 1998; 95(1)69–75
   PubMed Web of Science ®Google Scholar
• Henderson R.A., Watkins S.C., Flynn J.L. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J. Immunol. 1997; 159(2)635–643
   PubMed Web of Science ®Google Scholar
• Thurnher M., Ramoner R., Gastl G., Radmayr C., Bock G., Herold M., Klocker H., Bartsch G. Bacillus Calmette-Guerin mycobacteria stimulate human blood dendritic cells. Int. J. Cancer 1997; 70(1)128–134
   PubMed Web of Science ®Google Scholar
• Kim K.D., Lee H.G., Kim J.K., Park S.N., Choe I.S., Choe Y.K., Kim S.J., Lee E., Lim J.S. Enhanced antigen-presenting activity and tumour necrosis factor-alpha-independent activation of dendritic cells following treatment with Mycobacterium bovis bacillus Calmette-Guerin. Immunology 1999; 97(4)626–633
   PubMed Web of Science ®Google Scholar
• Tsuji S., Matsumoto M., Takeuchi O., Akira S., Azuma I., Hayashi A., Toyoshima K., Seya T. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: involvement of toll-like receptors. Infect. Immun. 2000; 68(12)6883–6890
   PubMed Web of Science ®Google Scholar
• Cheadle E.J., Selby P.J., Jackson A.M. Mycobacterium bovis bacillus Calmette-Guerin-infected dendritic cells potently activate autologous T cells via a B7 and interleukin-12-dependent mechanism. Immunology. 2003; 108(1)79–88
   PubMed Web of Science ®Google Scholar
• Ramoner R., Rieser C., Herold M., Klocker H., Bartsch G., Stenzl A., Thurnher M. Activation of human dendritic cells by bacillus Calmette-Guerin. J. Urol. 1998; 159(5)1488–1492
   PubMed Web of Science ®Google Scholar
• Harboe M. Antigens of PPD, old tuberculin, and autoclaved Mycobacterium bovis BCG studied by crossed immunoelectrophoresis. Am. Rev. Respir. Dis. 1981; 124(1)80–87
   PubMedGoogle Scholar
• Kitaura H., Kinomoto M., Yamada T. Ribosomal protein L7 included in tuberculin purified protein derivative (PPD) is a major heat-resistant protein inducing strong delayed-type hypersensitivity. Scand. J. Immunol. 1999; 50(6)580–587
   PubMed Web of Science ®Google Scholar
• Salvetti M., Ristori G., Buttinelli C., Fiori P., Falcone M., Britton W., Adams E., Paone G., Grasso M.G., Pozzilli C. The immune response to mycobacterial 70-kDa heat shock proteins frequently involves autoreactive T cells and is quantitatively disregulated in multiple sclerosis. J. Neuroimmunol. 1996; 65(2)143–153
   PubMed Web of Science ®Google Scholar
• Mustafa A.S., Lundin K.E., Meloen R.H., Shinnick T.M., Oftung F. Identification of promiscuous epitopes from the Mycobacterial 65-kilodalton heat shock protein recognized by human CD4(+) T cells of the Mycobacterium leprae memory repertoire). Infect. Immun. 1999; 67(11)5683–5689
   PubMed Web of Science ®Google Scholar
• Flohe S.B., Bruggemann J., Lendemans S., Nikulina M., Meierhoff G., Flohe S., Kolb H. Human heat shock protein 60 induces maturation of dendritic cells versus a Th1-promoting phenotype. J. Immunol. 2003; 170(5)2340–2348
   PubMed Web of Science ®Google Scholar
• Bethke K., Staib F., Distler M., Schmitt U., Jonuleit H., Flohe S., Kolb H. Different efficiency of heat shock proteins (HSP) to activate human monocytes and dendritic cells: superiority of HSP60. J. Immunol. 2002; 169(11)6141–6148
   PubMed Web of Science ®Google Scholar
• Jung S.B., Song C.H., Yang C.S., Kim S.Y., Lee K.S., Shin A.R., Lee J.S., Nam H.S., Kim H.J., Park J.K., Paik T.H., Jo E.K. Role of the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in the secretion of tumor necrosis factor-alpha and interleukin-10 by the PPD antigen of Mycobacterium tuberculosis. J. Clin. Immunol. 2005; 25(5)482–490
   PubMed Web of Science ®Google Scholar
• Peetermans W.E., Raats C.J., van Furth R., Langermans J.A. Mycobacterial 65-kilodalton heat shock protein induces tumor necrosis factor alpha and interleukin 6, reactive nitrogen intermediates, and toxoplasmastatic activity in murine peritoneal macrophages. Infect. Immun. 1995; 63(9)3454–3458
   PubMed Web of Science ®Google Scholar
• Kadowaki N., Ho S., Antonenko S., Malefyt R.W., Kastelein R.A., Bazan F., Liu Y. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 2001; 194(6)863–869
   PubMed Web of Science ®Google Scholar
• Werling D., Hope J.C., Howard C.J., Jungi T.W. Differential production of cytokines, reactive oxygen and nitrogen by bovine macrophages and dendritic cells stimulated with Toll-like receptor agonists. Immunol. 2004; 111(1)41–52
   PubMed Web of Science ®Google Scholar
• Agrawal S., Agrawal A., Doughty B., Gerwitz A., Blenis J., Van Dyke T., Pulendran B. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J. Immunol. 2003; 171(10)4984–4989
   PubMed Web of Science ®Google Scholar
• Watts C., Zaru R., Prescott A.R., Wallin R.P., West M.A. Proximal effects of Toll-like receptor activation in dendritic cells. Curr. Opin. Immunol. 2007; 19(1)73–78
   PubMed Web of Science ®Google Scholar
• Uehori J., Matsumoto M., Tsuji S., Akazawa T., Takeuchi O., Akira S., Kawata T., Azuma I., Toyoshima K., Seya T. Simultaneous blocking of human Toll-like receptors 2 and 4 suppresses myeloid dendritic cell activation induced by Mycobacterium bovis bacillus Calmette-Guérin peptidoglycan. Infect. Immun. 2003; 71(8)4238–4249
   PubMed Web of Science ®Google Scholar
• Bulut Y., Michelsen K.S., Hayrapetian L., Naiki Y., Spallek R., Singh M., Arditi M. Mycobacterium tuberculosis heat shock proteins use diverse Toll-like receptor pathways to activate pro-inflammatory signals. J. Biol. Chem. 2005; 280(22)20961–20967
   PubMed Web of Science ®Google Scholar
• Fricke I., Mitchell D., Mittelstädt J., Lehan N., Heine H., Goldmann T., Böhle A., Brandau S. Mycobacteria induce IFN-gamma production in human dendritic cells via triggering of TLR2. J. Immunol. 2006; 176(9)5173–5182
   PubMed Web of Science ®Google Scholar
• Takeda K., Akira K. Toll-like receptors in innate immunity. Int. Immunol. 2005; 17(1)1–14
   PubMed Web of Science ®Google Scholar
• Bausinger H., Lipsker D., Ziylan U., Manie S., Briand J.P., Cazenave J.P., Muller S., Haeuw J.F., Ravanat C., de la Salle H., Hanau D. Endotoxin-free heat-shock protein 70 fails to induce APC activation. Eur. J. Immunol. 2002; 32(12)3708–3713
   PubMed Web of Science ®Google Scholar
• Nersting J., Svenson M., Andersen V., Bendtzen K. Maturation of human dendritic cells by monocyte-conditioned medium is dependent upon trace amounts of lipopolysaccharide inducing tumour necrosis factor alpha. Immunol. Lett. 2003; 89(1)59–65
   PubMed Web of Science ®Google Scholar
• Cooper J.F., Weary M.E., Jordan F.T. The impact of non-endotoxin LAL-reactive materials on Limulus amebocyte lysate analyses. PDA J. Pharm. Sci. Technol. 1997; 51(1)2–6
   PubMedGoogle Scholar
• Tsuchiya M., Takaoka A., Tokioka N., Matsuura S. Development of an endotoxin-specific Limulus amebocyte lysate test blocking beta-glucan-mediated pathway by carboxymethylated curdlan and its application. Nippon Saikingaku Zasshi. 1990; 45(6)903–911
   PubMedGoogle Scholar
• Vassallo R., Limper A.H. Fungal beta-glucan can yield false-positive results with the limulus amebocyte lysate endotoxin assay. Chest 1999; 116(2)583–584
   PubMedGoogle Scholar
• Ikemura K., Ikegami K., Shimazu T., Yoshioka T., Sugimoto T. False-positive result in Limulus test caused by Limulus amebocyte lysate-reactive material in immunoglobulin products. J. Clin. Microbiol. 1989; 27(9)1965–1968
   PubMed Web of Science ®Google Scholar